NorthRock Partners LLC Has $372,000 Stock Position in Colgate-Palmolive (NYSE:CL)

NorthRock Partners LLC cut its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 3.2% in the first quarter, Holdings Channel reports. The firm owned 4,130 shares of the company’s stock after selling 135 shares during the period. NorthRock Partners LLC’s holdings in Colgate-Palmolive were worth $372,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Union Savings Bank raised its position in shares of Colgate-Palmolive by 76.6% in the fourth quarter. Union Savings Bank now owns 309 shares of the company’s stock valued at $25,000 after purchasing an additional 134 shares during the period. PSI Advisors LLC grew its stake in Colgate-Palmolive by 4,971.4% in the 1st quarter. PSI Advisors LLC now owns 355 shares of the company’s stock valued at $32,000 after buying an additional 348 shares during the last quarter. Avion Wealth raised its holdings in Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares during the period. Atlantic Edge Private Wealth Management LLC acquired a new position in Colgate-Palmolive during the 4th quarter worth $32,000. Finally, Core Wealth Advisors Inc. boosted its holdings in Colgate-Palmolive by 56.6% during the fourth quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after acquiring an additional 146 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In related news, insider John W. Kooyman sold 3,497 shares of the stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares in the company, valued at $297,328.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider John W. Kooyman sold 3,497 shares of the company’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total value of $326,864.59. Following the sale, the insider now directly owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Sally Massey sold 12,226 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the transaction, the insider now owns 13,924 shares of the company’s stock, valued at $1,309,691.44. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of several recent analyst reports. Stifel Nicolaus lifted their price target on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, April 29th. Barclays boosted their target price on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 30th. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $101.00 to $103.00 and gave the company an “overweight” rating in a report on Tuesday, May 28th. Citigroup boosted their price objective on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Finally, Bank of America increased their target price on shares of Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Three equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $95.33.

View Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Trading Down 0.8 %

CL traded down $0.81 during mid-day trading on Monday, hitting $97.26. The stock had a trading volume of 3,093,622 shares, compared to its average volume of 4,407,232. The stock’s fifty day simple moving average is $95.20 and its 200-day simple moving average is $89.08. The firm has a market capitalization of $79.80 billion, a price-to-earnings ratio of 30.78, a price-to-earnings-growth ratio of 3.61 and a beta of 0.39. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $99.08. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.73 earnings per share. As a group, research analysts forecast that Colgate-Palmolive will post 3.53 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, July 19th. This represents a $2.00 annualized dividend and a yield of 2.06%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.